Shuttle Pharmaceuticals Holdings Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Shuttle Pharmaceuticals Holdings Inc 's ROA in the second quarter of 2026?
Shuttle Pharmaceuticals Holdings Inc recorded a cumulative net loss of $-10 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -84.54%.

However, within the Healthcare sector 701 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4374, from total ROA ranking in the first quarter of 2026 at 5168.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	314.63 %	122.39 %	365.12 %	826.23 %	119.53 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-10	-11	-12	-11	-12
Return On Assets (TTM)	-84.54 %	-138.6 %	-189.59 %	-258.15 %	-361.71 %
SHPH's Total Ranking	# 4374	# 5168	# 4658	# 4774	# 4858
Total Assets (TTM) in million	23	12	10	4	6
Seq. Total Assets Change	93.26 %	13.84 %	192.8 %	-35.63 %	3.66 %
Seq. Net Income Change	-	-	-	-	-

SHPH's 5 Years Annual ROA >> Back to SHPH Management Effectiveness >> Compare SHPH ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 320
Sector	# 702
Overall	# 4157

Return On Assets Statistics
High	Average	Low
-45.62 %	-161.6 %	-370.41 %
(Mar 31 2023)		(Mar 31 2025)

Financial Statements
Shuttle Pharmaceuticals Holdings Inc 's Assets	$ 23 million	SHPH's Balance sheet
Shuttle Pharmaceuticals Holdings Inc 's Income	$ -3 million	Quarterly SHPH's Income Statement
SHPH's Income by Division		See SHPH's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	FY
Y / Y Total Assets Change	365.12 %	-60.3 %	-35.08 %	-	-
Total Assets in million	10	2	6	9	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-12	-9	-7	-3	0
Annual Return On Assets	-113 %	-410.03 %	-117.35 %	-35 %	-

SHPH's 5 Years Annual ROA >> Back to SHPH Management Effectiveness >> Compare SHPH ROA to its Competitors

More Return On Assets Ratios
SHPH's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SHPH's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SHPH's Competitors
Subscribers only: Roa for Shuttle Pharmaceuticals Holdings Inc 's Suppliers
Subscribers only: Return On Assets for SHPH's Customers

You may also want to know
SHPH's Roi	SHPH's Inventory Turnover Ratio	SHPH's Growth Rates	SHPH's Dividend Comparisons
	SHPH's Profitability Ratios	SHPH's Asset Turnover Ratio	SHPH's Dividend Growth
SHPH's Roe	SHPH's Valuation Ratios	SHPH's Financial Strength Ratios	SHPH's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-25T05:02:31+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.